BY DEBU TRIPATHY | DECEMBER 10, 2011
Dr. Debu Tripathy discusses how a test, a variation of the Oncotype DX test, could help physicians decide on radiation therapy for their patients diagnosed with ductal carcinoma in situ (DCIS).
There are no comments for this entry.
Your comment will appear once approved by CURE staff:
* Required fields
CURE Media Group
| Contact Us
| CMG Corporate
| Cancer Continuum
| Write for CURE
| Join the CURE Survey Panel
| My Account
© 2013 CURE Media Group. All rights reserved. SitemapCURE does not provide medical, diagnostic, or treatment advice.